Filing Details
- Accession Number:
- 0001209191-14-044385
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-06-30 16:06:05
- Reporting Period:
- 2014-06-26
- Filing Date:
- 2014-06-30
- Accepted Time:
- 2014-06-30 16:06:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1488613 | Foundation Medicine Inc. | FMI | Services-Medical Laboratories (8071) | 271316416 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1585005 | J. Steven Kafka | 150 Second Street C/O Foundation Medicine, Inc. Cambridge MA 02141 | Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2014-06-26 | 5,000 | $4.16 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2014-06-26 | 5,000 | $25.19 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2014-06-26 | 5,000 | $0.00 | 5,000 | $4.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 123,000 | 2023-03-07 | No | 4 | M | Direct |
Footnotes
- The exercise reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014.
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 19, 2014.
- The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $25.0000 to $25.2750, inclusive. The reporting person undertakes to provide Foundation Medicine, Inc., any security holder of Foundation Medicine, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
- This option was granted on March 7, 2013. Twenty-five percent vested on January 2, 2014 and an additional 6.25% vests each successive quarter thereafter until fully vested on January 2, 2017.
Billionaire Hedge Funds
